<?xml version="1.0" encoding="UTF-8"?>
<p id="Par22">Data were retrospectively collected and included demographic information, underlying diseases (comorbidities are defined in Additional file 
 <xref rid="MOESM1" ref-type="media">1</xref>), clinical symptoms, vital signs, laboratory and radiological findings at admission, community-acquired respiratory co-infections (Additional file 
 <xref rid="MOESM1" ref-type="media">1</xref> [
 <xref ref-type="bibr" rid="CR16">16</xref>]), clinical management (administration of NAIs, systemic corticosteroids, vasopressor agents, invasive and non-invasive mechanical ventilation) and outcomes (admittance to ICU, length of hospital stay and 30-day mortality). Patients with hospital stays &lt; 30 days were followed up by phone calls to determine survival status.
</p>
